Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

Pivotal Therapeutics Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:PVTTF
FechaHoraFuenteTítuloSímboloCompañía
05/05/201416:22MarketwiredCrossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.USOTC:PVTTFPivotal Therapeutics Inc (CE)
07/10/201315:39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201307:54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201312:49OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
13/09/201312:46OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
05/09/201311:45OTC MarketsPIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATEUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201314:24OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/08/201314:11OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201323:44OTC MarketsAnnual ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201323:33OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
29/05/201311:34OTC MarketsPivotal Therapeutics Announces First Quarter 2013 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
07/05/201309:55OTC MarketsPivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/05/201311:07OTC MarketsPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201317:08OTC MarketsPivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...USOTC:PVTTFPivotal Therapeutics Inc (CE)
29/04/201319:38OTC MarketsPivotal Therapeutics Announces 2012 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
16/04/201314:00ZacksPivotal Progresses with Vascazen - Analyst BlogUSOTC:PVTTFPivotal Therapeutics Inc (CE)
09/04/201307:45OTC MarketsPivotal Therapeutics VASCAZEN® - Meets Primary Endpoint in Reveal Trial - Top Line Results Accepted for Presentation at t...USOTC:PVTTFPivotal Therapeutics Inc (CE)
06/03/201311:42OTC MarketsPivotal Therapeutics Exhibiting at the American College of Cardiology's 62nd Annual Scientific Session and EXPOUSOTC:PVTTFPivotal Therapeutics Inc (CE)
29/11/201217:12OTC MarketsHome Country News ReleaseUSOTC:PVTTFPivotal Therapeutics Inc (CE)
28/05/201215:31GlobeNewswire Inc.Pivotal Therapeutics Reports 1st Quarter 2012 ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:PVTTF